GYRE THERAPEUTICS, INC. — Investor Relations & Filings
Filings indexed
1,203
across all filing types
Latest filing
2026-05-04
Regulatory Filings
Country
US
United States of America
Listing
US
GYRE
Gyre Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for organ fibrosis and inflammatory diseases. The company develops small-molecule, anti-inflammatory, and anti-fibrotic drugs. Its lead drug candidate is Hydronidone (F351), which is being evaluated for the treatment of liver fibrosis, including cases associated with Chronic Hepatitis B (CHB) and Metabolic Dysfunction-Associated Steatohepatitis (MASH). The company's pipeline also includes other therapeutic candidates, such as Pirfenidone for pneumoconiosis, aimed at addressing unmet medical needs in chronic organ diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer) | 2026-05-04 | English | |
| ARS - GYRE THERAPEUTICS, INC. (0001124105) (Filer) | 2026-04-27 | English | |
| DEF 14A - GYRE THERAPEUTICS, INC. (0001124105) (Filer) | 2026-04-27 | English | |
| 8-K/A - GYRE THERAPEUTICS, INC. (0001124105) (Filer) | 2026-04-17 | English | |
| 8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer) | 2026-03-23 | English | |
| 8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer) | 2026-03-02 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 40912003 | 8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer) | 2026-05-04 | English | ||
| 37628110 | ARS - GYRE THERAPEUTICS, INC. (0001124105) (Filer) | 2026-04-27 | English | ||
| 37623763 | DEF 14A - GYRE THERAPEUTICS, INC. (0001124105) (Filer) | 2026-04-27 | English | ||
| 34656951 | 8-K/A - GYRE THERAPEUTICS, INC. (0001124105) (Filer) | 2026-04-17 | English | ||
| 33012966 | 8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer) | 2026-03-23 | English | ||
| 32887857 | 8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer) | 2026-03-02 | English | ||
| 28004214 | 4 Filing | 2026-01-09 | English | ||
| 28004105 | 4 Filing | 2026-01-09 | English | ||
| 28004227 | 8-K Filing | 2026-01-05 | English | ||
|
2025
6 filings
| |||||
| 11376423 | Regulatory Filings 2025 | 2025-11-13 | English | ||
| 11376429 | 10-Q | 2025-11-07 | English | ||
| 11376430 | 8-K | 2025-11-06 | English | ||
| 11376421 | 8-K | 2025-09-10 | English | ||
| 11376422 | FORM 4 | 2025-08-26 | English | ||
| 11376431 | FORM 3 | 2025-08-26 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
GYRE THERAPEUTICS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32556/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32556 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32556 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32556 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32556}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GYRE THERAPEUTICS, INC. (id: 32556)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.